Aspireo Reports Data in Further Phase Ib Study
Aspireo Pharmaceuticals Limited (“Aspireo”), an Israeli biopharmaceutical company, focused on the development of Somatop…
Aspireo Pharmaceuticals Limited (“Aspireo”), an Israeli biopharmaceutical company, focused on the development of Somatop…
Aspireo Pharmaceuticals Limited ("Aspireo"), an Israeli biopharmaceutical company, focused on the development of Somatop…
Aspireo Pharmaceuticals Limited, ("Aspireo") an Israeli biopharmaceutical company, focused on the development of Somatop…
Aspireo Pharmaceuticals Limited, ("Aspireo") an Israeli biopharmaceutical company, focused on the development of Somatop…
. - Teaming up to partner Aspireo's Somatoprim (DG3173) Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX) and Aspir…
. - Zielsetzung ist die Kommerzialisierung von Somatoprim (DG3173) Evotec AG (Frankfurter Wertpapierbörse: EVT, Tec…
DeveloGen AG, ein privates biopharmazeutisches Unternehmen, welches innovative Therapien zur Behandlung von metabolische…
DeveloGen AG, a privately held biopharmaceutical company developing novel therapeutics for the treatment of metabolic an…
DeveloGen AG, ein privates biopharmazeutisches Unternehmen, welches neuartige Therapien zur Behandlung von metabolischen…